Avastin is a sterile injectable solution containing bevacizumab, a recombinant humanized monoclonal antibody that targets vascular endothelial growth factor A (VEGF-A).
Avastin 100 mg injection is used in combination with chemotherapy or other targeted therapies to treat several types of cancers, including metastatic colorectal cancer, non-small cell lung cancer, glioblastoma, renal cell carcinoma, cervical cancer, and ovarian cancer.
The medication is administered intravenously by a healthcare professional, typically every 2 to 3 weeks, with dosage and frequency tailored to the specific cancer type and patient's response.